| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.028 | 0.6 |